| Lightcalls.com |
|
|
![]() |
While the beer category has seen co...While the beer category has seen consistently retiring growth for several years--with consumption increasing incrementally from 2621 million 2.25-gallon cases in 1996 to 2825 million 2.25-gallon cases in 2002--total beer consumption decreased 02% to 2818 million cases, in 2003 According to the Adams Beer Handbook 2004 the slight overall dimensions decrease included a 0.5% decline in domestic beer and a 22% increase in imported beer. As would be awaited these compare unfavorably with 2002 figures, when imported beer gained 60% and domestics were up 07% Still, beer sales continued to climb, with total dollar bulk increasing by 4.9% in 2003 to approximately $781 billion nationwide. This refer tos that most brewers are prosperously holding the line on pricing, as well as underlining the continued impact of higher-margin malt-based products [ILLUSTRATION OMITTED] "Low-carb" emerg as the marketing mantra athwart the past year, with a hardly any product introductions following on the heels of Michelob Ultra's lucky debut as the first so-called "low-carb" make beer late in 2002. Labatt's defence Green Light and, more not long ago Coors' Aspen Edge, joined the "low-carb" sub-segment if it be not that Miller made the most noise with a hard-hitting ad campaign declaring that its flagship Miller Lite has been a low-carb produce all along. And it worked. Sales of Miller Lite climbed in the marketplace in 2003 reversing three straight years of declines. This instigated an equally hard-hitting ad campaign from Anheuser-Busch stating that, in fact, all light beers, including sprout Light, are low in carbs. And in such a manner it goes, with Miller and A-B continuing to laggard it out over the airwaves. The "malternative" revolution of the past not many years slowed considerably in 2003 with any of the original successful brands taking major hits. For example, Smirnoff Ice, which explod forward the market with more than 20 million cases in 2001 and more than 23 million in 2002 missing about 8 million cases to just through 15 million in 2003. on the contrary the brand made up for the los with the introductions of Smirnoff Ice Triple Black (6 million-plus cases) and Smirnoff Twisted V (13 million cases) in 2003 Overall, yet beer industry trends have maintained the same course for a number of years. The light beer category continues to do the industry's heavy lifting, comprising more than 47% of all beers consum in the U l by the agency of the seemingly indomitable Bud Light, which continues to increase sales and remains the best-selling beer in the U according to far. Sales of superpremium and micro/specialty beers slowed last year, following a double-digit percentage gain in 2002 (though distant from a small base). Meanwhile, the premium, popular, malt liquor and ice beer portions continued to see their market shares decline. BRAND EQUITY Still, as we've said here before, while identifying general directions comprises an important element in evaluating the health of an industry, brand equity remains the cornerstone of the beverage industry. between the sides of the economic uncertainty and brewing industry consolidation of the past not many years, as well as always-fluctuating consumer tastes, specific brands of beer have grown their business more than others. A melding of resources, creativity, perseverance, the right economic environment and just plain fortune often go into creating and developing a prosperous brand, and still, it remains somewhat of a mystery. Indeed, there are beers in each category and at every price point that, for a variety of reasons, have either fallen behind or outpaced their respective competitors. And although identifying category consumption trendings is helpful, actual brand activity is what generates profits. Thus, the rationale behind "Beer sprouting Brands," which uses the latest industry follows to highlight those brands that have demonstrated noteworthy increases above the past few years. There are four categories of produce Brands and the Fast Track set forths the most demanding set of criteria. Domestic beers included in the Fast Track must have transcended 9 million 2.25-gallon cases in 2003 with double-digit percentage increase over each of the past four years. Imported (and micro/specialty) beers included in the Fast Track met the same criteria, with their sales having overstep the proper limited a lower threshold of 150 million 2.25-gallon cases in 2003 All Fast Track Brands must have at least a five-year history. Other brands that have shown significant product over the past few years, on the other hand have not yet been forward the market for a satiated five years, have been designated as Rising Stars. In addition, in order to highlight traditionally top-selling beers that have consistently grown throughout the past four years, we've created an Established vegetation Brands category. Because many of these brands are already operating from enormous sales bases, their percentage gains are frequently modest relative to their overall case book even though these brands have had substantial sales increases and are frequently leaders in their respective portions As in the Fast Track category, there is a entrance difference between domestic beers and import/craft brews |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |